FDA Approves Janssen, Legend Biotech's CAR T-Cell Therapy Carvykti for Multiple Myeloma

Retrieved on: 2022-03-01 20:47:07

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Janssen, Legend Biotech's CAR T-Cell Therapy Carvykti for Multiple Myeloma. View article details on hiswai:

Excerpt

... an immunomodulatory agent, and an anti-CD38 monoclonal antibody. ... two single-domain antibodies to target the B-cell maturation antigen, ...

Article found on: www.precisiononcologynews.com